Literature DB >> 18945415

Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.

Sun Kuie Tay1, Hextan Y S Ngan, Tang-Yuan Chu, Annie N Y Cheung, Eng Hseon Tay.   

Abstract

Hong Kong, Singapore and Taiwan are three island states that are newly emerged affluent economic areas in Asia. The majority of the populations are ethnically Chinese with a total population of 6.98, 4.5 and 23 million, respectively. Cervical cancer has been declining over the last thirty years in all three states and is largely attributable to widespread opportunistic cervical cancer screening. The age-standardized incidence rates of cervical cancer are 9.6 per 100,000 women in Hong Kong in 2004, 10.6 per 100,000 women in Singapore in 2002 and 18.6 per 100,000 women in Taiwan in 2003. High prevalence of human papillomavirus (HPV) was observed in all three states. In cervical cancer, HPV 16 and 18 are the two most prevalent HPV types, but HPV 58 and 52 are also highly prevalent in these three states. Important epidemiological risk factors for invasive cervical cancer include smoking and age at sexual debut for women, although this is changing towards an earlier age. Of the three states, Taiwan was the first to have a comprehensive national screening programme in 1995 followed by Hong Kong in 2002 and Singapore in 2004. Women in these three states are well aware of cervical cancer and the preventative means by Pap smear screening, although their awareness and understanding of the role of HPV in cervical carcinogenesis is low. Prophylactic HPV vaccines have been licensed in the three states. Routine comprehensive public vaccination programme for adolescent girls has yet to be adopted by the governmental agency, despite an affirmative recommendation by medical professional bodies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18945415     DOI: 10.1016/j.vaccine.2008.05.042

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  11 in total

1.  Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay and comparison with the Roche Linear Array HPV genotyping assay.

Authors:  Stephanie S Liu; Rebecca C Y Leung; Karen K L Chan; Annie N Y Cheung; Hextan Y S Ngan
Journal:  J Clin Microbiol       Date:  2009-12-30       Impact factor: 5.948

2.  Asia oceania guidelines for the implementation of programs for cervical cancer prevention and control.

Authors:  Hextan Y S Ngan; Suzanne M Garland; Neerja Bhatla; Sonia R Pagliusi; Karen K L Chan; Annie N Y Cheung; Tang-Yuan Chu; Efren J Domingo; You Lin Qiao; Jong Sup Park; Eng Hseon Tay; Wisit Supakarapongkul
Journal:  J Cancer Epidemiol       Date:  2011-04-13

3.  Cost-effectiveness of different human papillomavirus vaccines in Singapore.

Authors:  Vernon J Lee; Sun Kuie Tay; Yee Leong Teoh; Mei Yin Tok
Journal:  BMC Public Health       Date:  2011-03-31       Impact factor: 3.295

4.  Global challenges of implementing human papillomavirus vaccines.

Authors:  Janice E Graham; Amrita Mishra
Journal:  Int J Equity Health       Date:  2011-06-30

5.  Incidence, Trends and Ethnic Differences of Oropharyngeal, Anal and Cervical Cancers: Singapore, 1968-2012.

Authors:  Jennifer O Lam; Wei-Yen Lim; Khuan-Yew Chow; Gypsyamber D'Souza
Journal:  PLoS One       Date:  2015-12-31       Impact factor: 3.240

6.  Pelvic inflammatory disease increases the risk of a second primary malignancy in patients with cervical cancer treated by surgery alone.

Authors:  Wen-Yen Chiou; Chien-An Chen; Moon-Sing Lee; Hon-Yi Lin; Chung-Yi Li; Yu-Chieh Su; Shiang-Jiun Tsai; Shih-Kai Hung
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Facilitators and barriers to the acceptance of human papillomavirus (HPV) vaccination among adolescent girls: a comparison between mothers and their adolescent daughters in Hong Kong.

Authors:  Alice Yuen Loke; Ava Chiu Oi Chan; Yuen Ting Wong
Journal:  BMC Res Notes       Date:  2017-08-10

8.  Risk of cancer in patients with genital warts: A nationwide, population-based cohort study in Taiwan.

Authors:  Ching-Yi Cho; Yu-Cheng Lo; Miao-Chiu Hung; Chou-Cheng Lai; Chun-Jen Chen; Keh-Gong Wu
Journal:  PLoS One       Date:  2017-08-14       Impact factor: 3.240

9.  Cost-effectiveness of human papillomavirus vaccination for prevention of cervical cancer in Taiwan.

Authors:  Pang-Hsiang Liu; Fu-Chang Hu; Ping-Ing Lee; Song-Nan Chow; Chao-Wan Huang; Jung-Der Wang
Journal:  BMC Health Serv Res       Date:  2010-01-11       Impact factor: 2.655

10.  Knowledge, Decision-Making and Acceptance of Human Papilloma Virus Vaccination among Parents of Primary Schoolzzm321990Students in Kota Bharu, Kelantan, Malaysia

Authors:  Mastura Mohd Sopian; Juwita Shaaban; Siti Suhaila Mohd Yusoff; Wan Mohd Zahiruddin Wan Mohamad
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.